Most Read Articles
13 Oct 2017
Higher circulating levels of docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA) appear to be protective against incident atherothrombotic and cardioembolic strokes, respectively, according to a recent study.
Roshini Claire Anthony, 11 Oct 2017

The prevalence of resistant hypertension may be lower than expected, particularly once pseudo-resistant hypertension due to treatment nonadherence is taken into account, according to a presentation at the recent APCH 2017.

Pank Jit Sin, 07 Jan 2015

Cardiovascular diseases (CVD) have been the main cause of death in the Malaysian population since 2007. This trend has continued, with the number of people dying from CVD-related causes increasing year on year. 

Tristan Manalac, 12 Oct 2017
Administration of a long-acting medication at the time that is most suitable for maximum patient compliance is the best approach in controlling blood pressure, said Dr. Trefor Morgan at the recently concluded 13th Asian-Pacific Congress of Hypertension (APCH 2017), held at the Suntec Singapore Convention and Exhibition Centre.

Long-term risk of recurrent stroke high in stroke, TIA survivors with no early complications

17 Aug 2017

Survivors of stroke or transient ischaemic attack (TIA) with no early complications suffer from higher long-term risks of recurrent stroke and admission into an institution, a new study has found.

The study included 26,366 stroke or TIA patients (median age 72 years; 46.9 percent female) who survived for 90 days without complications. Controls (n=263,660; mean age 72 years; 46.9 percent female) were matched for geographic location, sex and age. Rates of composite and individual outcomes of death, stroke, myocardial infarction (MI) or admission to continuing care were calculated at 1, 3 and 5 years.

At 1 year, 9.5 percent of the patients who were event-free at 90 days after stroke or TIA experienced the primary composite outcome.  The 3- and 5-year composite outcome rates were 23.6 and 35.7 percent, respectively. Rates were higher than in the corresponding controls (5.4, 13.6 and 21.1 percent, respectively).

Five-year rates of the secondary outcomes of stroke (7.8 vs 1.6 percent), MI (3.9 vs 2.5 percent), admission to continuing care (8.9 vs 4.7 percent) and death (26.0 vs 16.9 percent) were all higher in cases than in controls.

The risk for the primary outcome in cases was more than twice than in controls at 1 year (hazard ratio [HR], 2.4; 95 percent CI, 2.3 to 2.5). This was consistent at 3 (HR, 2.2; 2.1 to 2.3) and 5 (HR, 2.1; 2.1 to 2.2) years.

Long-term risk of recurrent stroke in cases at 1 (HR, 6.8;6.1 to 7.5), 3 (HR, 5.6; 5.2 to 6.0) and 5 (HR, 5.1; 4.8 to 5.5) years was the highest among all outcomes examined.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
13 Oct 2017
Higher circulating levels of docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA) appear to be protective against incident atherothrombotic and cardioembolic strokes, respectively, according to a recent study.
Roshini Claire Anthony, 11 Oct 2017

The prevalence of resistant hypertension may be lower than expected, particularly once pseudo-resistant hypertension due to treatment nonadherence is taken into account, according to a presentation at the recent APCH 2017.

Pank Jit Sin, 07 Jan 2015

Cardiovascular diseases (CVD) have been the main cause of death in the Malaysian population since 2007. This trend has continued, with the number of people dying from CVD-related causes increasing year on year. 

Tristan Manalac, 12 Oct 2017
Administration of a long-acting medication at the time that is most suitable for maximum patient compliance is the best approach in controlling blood pressure, said Dr. Trefor Morgan at the recently concluded 13th Asian-Pacific Congress of Hypertension (APCH 2017), held at the Suntec Singapore Convention and Exhibition Centre.